The University of Chicago Header Logo

Connection

Arthur Herbst to Female

Back to Details
This is a "connection" page, showing publications Arthur Herbst has written about Female.
Arthur Herbst
Connection Strength
0.543
Female
  1. Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix. N Engl J Med. 2018 05 03; 378(18):1746-1748.
    View in: PubMed
    Score: 0.030
  2. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up. Gynecol Oncol. 2017 09; 146(3):566-571.
    View in: PubMed
    Score: 0.028
  3. Diethylstilbestrol (DES) Pregnancy Treatment: A Promising Widely Used Therapy with Unintended Adverse Consequences. AMA J Ethics. 2015 Sep 01; 17(9):865-70.
    View in: PubMed
    Score: 0.025
  4. Influence of mode of delivery on neonatal mortality in the second twin, at and before term. BJOG. 2008 Nov; 115(12):1512-7.
    View in: PubMed
    Score: 0.015
  5. The management of ASCUS cervical cytologic abnormalities and HPV testing: a cautionary note. Obstet Gynecol. 2001 Nov; 98(5 Pt 1):849-51.
    View in: PubMed
    Score: 0.009
  6. Re: van Nagell JR Jr, et al. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer. Gynecol Oncol 2000; 77: 350-6. Gynecol Oncol. 2001 Mar; 80(3):421; author reply 422.
    View in: PubMed
    Score: 0.009
  7. Risk factors for diethylstilbestrol-associated clear cell adenocarcinoma. Obstet Gynecol. 2000 Jun; 95(6 Pt 1):814-20.
    View in: PubMed
    Score: 0.009
  8. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES). Gynecol Oncol. 2000 Feb; 76(2):147-56.
    View in: PubMed
    Score: 0.008
  9. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971. Am J Obstet Gynecol. 1999 Dec; 181(6):1574-5.
    View in: PubMed
    Score: 0.008
  10. Diethylstilbestrol and adenocarcinoma of the vagina. Am J Obstet Gynecol. 1999 Dec; 181(6):1576-8; discussion 1579.
    View in: PubMed
    Score: 0.008
  11. Reproductive and hormone-related outcomes in women whose mothers were exposed in utero to diethylstilbestrol (DES): A report from the US National Cancer Institute DES Third Generation Study. Reprod Toxicol. 2019 03; 84:32-38.
    View in: PubMed
    Score: 0.008
  12. Risk factors for acidemia at birth. Obstet Gynecol. 1997 Jul; 90(1):125-30.
    View in: PubMed
    Score: 0.007
  13. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract. Am J Obstet Gynecol. 2016 09; 215(3):322.e1-8.
    View in: PubMed
    Score: 0.006
  14. Self-reported allergy, infection, and autoimmune diseases among men and women exposed in utero to diethylstilbestrol. J Clin Epidemiol. 1996 Feb; 49(2):263-6.
    View in: PubMed
    Score: 0.006
  15. Risk factors for fever in labor. Obstet Gynecol. 1995 Nov; 86(5):790-4.
    View in: PubMed
    Score: 0.006
  16. Age at menarche among diethylstilbestrol granddaughters. Am J Obstet Gynecol. 1995 Sep; 173(3 Pt 1):835-6.
    View in: PubMed
    Score: 0.006
  17. Fertility in men exposed prenatally to diethylstilbestrol. N Engl J Med. 1995 May 25; 332(21):1411-6.
    View in: PubMed
    Score: 0.006
  18. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt). 2015 Apr; 24(4):308-15.
    View in: PubMed
    Score: 0.006
  19. Onset of menopause in women exposed to diethylstilbestrol in utero. Am J Obstet Gynecol. 1995 Jan; 172(1 Pt 1):92-5.
    View in: PubMed
    Score: 0.006
  20. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma. Gynecol Oncol. 1994 Nov; 55(2):238-44.
    View in: PubMed
    Score: 0.006
  21. DES exposure: an update. Contemp Pediatr. 1994 Nov; 11(11):59-62, 64, 66 passim.
    View in: PubMed
    Score: 0.006
  22. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Obstet Gynecol. 1994 Sep; 84(3):404-8.
    View in: PubMed
    Score: 0.006
  23. Association of physical activity with glycaemic control and cardiovascular risk profile in 65 666 people with type 2 diabetes from Germany and Austria. Diabet Med. 2014 Aug; 31(8):905-12.
    View in: PubMed
    Score: 0.006
  24. The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease. Am J Obstet Gynecol. 1994 Apr; 170(4):1099-105; discussion 1105-7.
    View in: PubMed
    Score: 0.006
  25. Effects on the menstrual cycle of in utero exposure to diethylstilbestrol. Am J Obstet Gynecol. 1994 Mar; 170(3):709-15.
    View in: PubMed
    Score: 0.006
  26. Impact of contraception on gynecologic cancers. Am J Obstet Gynecol. 1993 Jun; 168(6 Pt 2):1980-5.
    View in: PubMed
    Score: 0.005
  27. Medical conditions among adult offspring prenatally exposed to diethylstilbestrol. Epidemiology. 2013 May; 24(3):430-8.
    View in: PubMed
    Score: 0.005
  28. Prenatal diethylstilbestrol exposure and performance on college entrance examinations. Horm Behav. 1992 Sep; 26(3):433-9.
    View in: PubMed
    Score: 0.005
  29. The Bethesda system for cervical/vaginal cytologic diagnoses. Clin Obstet Gynecol. 1992 Mar; 35(1):22-7.
    View in: PubMed
    Score: 0.005
  30. Does early exposure to maternal smoking affect future fertility in adult males? Reprod Toxicol. 1992; 6(4):297-307.
    View in: PubMed
    Score: 0.005
  31. Mammography screening behaviors of women exposed prenatally to diethylstilbestrol. J Womens Health (Larchmt). 2012 Feb; 21(2):209-14.
    View in: PubMed
    Score: 0.005
  32. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med. 2011 Oct 06; 365(14):1304-14.
    View in: PubMed
    Score: 0.005
  33. Concerns regarding the Bethesda System. Int J Gynecol Pathol. 1991; 10(4):326-8.
    View in: PubMed
    Score: 0.004
  34. Clear cell adenocarcinoma of the lower genital tract. Correlation of mother's recall of diethylstilbestrol history with obstetrical records. Cancer. 1990 Nov 15; 66(10):2215-20.
    View in: PubMed
    Score: 0.004
  35. Estimates of dose to intraperitoneal micrometastases from alpha and beta emitters in radioimmunotherapy. Gynecol Oncol. 1990 Sep; 38(3):478-85.
    View in: PubMed
    Score: 0.004
  36. The Bethesda System for cervical/vaginal cytologic diagnoses: a note of caution. Obstet Gynecol. 1990 Sep; 76(3 Pt 1):449-50.
    View in: PubMed
    Score: 0.004
  37. Medical professional liability and obstetric care: the Institute of Medicine report and recommendations. Obstet Gynecol. 1990 Apr; 75(4):705-9.
    View in: PubMed
    Score: 0.004
  38. Preoperative radiotherapy followed by radical vulvectomy with inguinal lymphadenectomy for advanced vulvar carcinomas. Gynecol Oncol. 1990 Feb; 36(2):181-4.
    View in: PubMed
    Score: 0.004
  39. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Semin Surg Oncol. 1990; 6(6):343-6.
    View in: PubMed
    Score: 0.004
  40. Comparison of short-lived high-LET alpha-emitting radionuclides lead-212 and bismuth-212 to low-LET X-rays on ovarian carcinoma. Gynecol Oncol. 1989 Dec; 35(3):297-300.
    View in: PubMed
    Score: 0.004
  41. Breast biopsy techniques. Clin Obstet Gynecol. 1989 Dec; 32(4):800-6.
    View in: PubMed
    Score: 0.004
  42. Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide in the treatment of small cell carcinoma of the ovary. Cancer. 1989 Sep 15; 64(6):1183-7.
    View in: PubMed
    Score: 0.004
  43. Pelvic exenteration in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol. 1989 Sep; 34(3):413-6.
    View in: PubMed
    Score: 0.004
  44. Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ Health. 2009 Aug 18; 8:37.
    View in: PubMed
    Score: 0.004
  45. The development of alpha-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma. Am J Obstet Gynecol. 1989 Apr; 160(4):789-97.
    View in: PubMed
    Score: 0.004
  46. Breast cancer screening in women exposed in utero to diethylstilbestrol. J Womens Health (Larchmt). 2009 Apr; 18(4):547-52.
    View in: PubMed
    Score: 0.004
  47. An evaluation of stage II vaginal clear cell adenocarcinoma according to substages. Gynecol Oncol. 1988 Sep; 31(1):56-64.
    View in: PubMed
    Score: 0.004
  48. Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol. J Low Genit Tract Dis. 2008 Apr; 12(2):111-7.
    View in: PubMed
    Score: 0.004
  49. Infertility among daughters either exposed or not exposed to diethylstilbestrol. Am J Obstet Gynecol. 1988 Mar; 158(3 Pt 1):493-8.
    View in: PubMed
    Score: 0.004
  50. Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation. Epidemiology. 2008 Mar; 19(2):251-7.
    View in: PubMed
    Score: 0.004
  51. Overview of therapeutic and prophylactic antibiotics in obstetrics and gynecology. J Reprod Med. 1988 Jan; 33(1 Suppl):144-8.
    View in: PubMed
    Score: 0.004
  52. Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix. Gynecol Oncol. 1988 Jan; 29(1):76-81.
    View in: PubMed
    Score: 0.004
  53. Local therapy in stage I clear cell adenocarcinoma of the vagina. Cancer. 1987 Sep 15; 60(6):1319-24.
    View in: PubMed
    Score: 0.004
  54. Secondary sex ratio among women exposed to diethylstilbestrol in utero. Environ Health Perspect. 2007 Sep; 115(9):1314-9.
    View in: PubMed
    Score: 0.004
  55. An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma. Am J Obstet Gynecol. 1987 Aug; 157(2):433-9.
    View in: PubMed
    Score: 0.004
  56. Cancer risk in women prenatally exposed to diethylstilbestrol. Int J Cancer. 2007 Jul 15; 121(2):356-60.
    View in: PubMed
    Score: 0.004
  57. Preeclampsia risk in women exposed in utero to diethylstilbestrol. Obstet Gynecol. 2007 Jul; 110(1):113-20.
    View in: PubMed
    Score: 0.004
  58. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. N Engl J Med. 1987 Feb 26; 316(9):514-6.
    View in: PubMed
    Score: 0.003
  59. The effects in the human of diethylstilbestrol (DES) use during pregnancy. Princess Takamatsu Symp. 1987; 18:67-75.
    View in: PubMed
    Score: 0.003
  60. Shorter remission period in young versus older children with diabetes mellitus type 1. Exp Clin Endocrinol Diabetes. 2007 Jan; 115(1):33-7.
    View in: PubMed
    Score: 0.003
  61. Age at natural menopause in women exposed to diethylstilbestrol in utero. Am J Epidemiol. 2006 Oct 01; 164(7):682-8.
    View in: PubMed
    Score: 0.003
  62. Prenatal diethylstilbestrol exposure and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1509-14.
    View in: PubMed
    Score: 0.003
  63. Mortality in women given diethylstilbestrol during pregnancy. Br J Cancer. 2006 Jul 03; 95(1):107-11.
    View in: PubMed
    Score: 0.003
  64. Birth weight and breast cancer risk. Br J Cancer. 2006 Jun 05; 94(11):1734-7.
    View in: PubMed
    Score: 0.003
  65. Clear cell adenocarcinoma (CCA) of the vagina and cervix in association with pregnancy. Gynecol Oncol. 1986 Jun; 24(2):207-19.
    View in: PubMed
    Score: 0.003
  66. Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES). Int J Epidemiol. 2006 Aug; 35(4):862-8.
    View in: PubMed
    Score: 0.003
  67. Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: a case-control study. Am J Obstet Gynecol. 1986 Apr; 154(4):814-22.
    View in: PubMed
    Score: 0.003
  68. Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma. Oncology. 1986; 43(1):12-7.
    View in: PubMed
    Score: 0.003
  69. Hypospadias in sons of women exposed to diethylstilbestrol in utero. Epidemiology. 2005 Jul; 16(4):583-6.
    View in: PubMed
    Score: 0.003
  70. Persistence and distribution of estrogen receptor in advanced epithelial ovarian carcinoma after chemotherapy. Obstet Gynecol. 1985 Feb; 65(2):257-63.
    View in: PubMed
    Score: 0.003
  71. Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure. Obstet Gynecol. 2005 Jan; 105(1):167-73.
    View in: PubMed
    Score: 0.003
  72. Diethylstilbestrol exposure--1984. N Engl J Med. 1984 Nov 29; 311(22):1433-5.
    View in: PubMed
    Score: 0.003
  73. The effect of lithium carbonate on chemotherapy-induced neutropenia and thrombocytopenia. Am J Hematol. 1984 May; 16(4):313-23.
    View in: PubMed
    Score: 0.003
  74. Nuclear DNA content of clear cell adenocarcinoma of the vagina and cervix and its relationship to prognosis. Gynecol Oncol. 1983 Apr; 15(2):230-8.
    View in: PubMed
    Score: 0.003
  75. Accuracy of three sampling technics for the diagnosis of endometrial cancer and hyperplasias. J Reprod Med. 1982 Oct; 27(10):622-6.
    View in: PubMed
    Score: 0.003
  76. Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States). Cancer Causes Control. 2002 Oct; 13(8):753-8.
    View in: PubMed
    Score: 0.003
  77. DES-related female genital changes. Semin Oncol. 1982 Sep; 9(3):341-8.
    View in: PubMed
    Score: 0.003
  78. Medical treatment of urethral prolapse in children. Obstet Gynecol. 1982 Jan; 59(1):69-74.
    View in: PubMed
    Score: 0.002
  79. Reproductive and gynecologic surgical experience in diethylstilbestrol-exposed daughters. Am J Obstet Gynecol. 1981 Dec 15; 141(8):1019-28.
    View in: PubMed
    Score: 0.002
  80. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control. 2001 Nov; 12(9):837-45.
    View in: PubMed
    Score: 0.002
  81. Diethylstilbestrol and other sex hormones during pregnancy. Obstet Gynecol. 1981 Nov; 58(5 Suppl):35S-40S.
    View in: PubMed
    Score: 0.002
  82. Infertility among women exposed prenatally to diethylstilbestrol. Am J Epidemiol. 2001 Aug 15; 154(4):316-21.
    View in: PubMed
    Score: 0.002
  83. Estrogen receptor and peroxidase activity in epithelial ovarian carcinomas. J Natl Cancer Inst. 1981 Aug; 67(2):307-18.
    View in: PubMed
    Score: 0.002
  84. Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer. 1981 Jul 15; 48(2 Suppl):484-8.
    View in: PubMed
    Score: 0.002
  85. Intrauterine infection may be a major cause of stillbirth in Sweden. Acta Obstet Gynecol Scand. 2001 Jun; 80(6):511-8.
    View in: PubMed
    Score: 0.002
  86. Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst. 2001 Apr 04; 93(7):545-51.
    View in: PubMed
    Score: 0.002
  87. Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer. 2001 Jan 05; 84(1):126-33.
    View in: PubMed
    Score: 0.002
  88. The current status of the DES-exposed population. Obstet Gynecol Annu. 1981; 10:267-78.
    View in: PubMed
    Score: 0.002
  89. DES update. Interview by Arthur I. Holleb. CA Cancer J Clin. 1980 Nov-Dec; 30(6):326-32.
    View in: PubMed
    Score: 0.002
  90. Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring. Obstet Gynecol. 2000 Oct; 96(4):483-9.
    View in: PubMed
    Score: 0.002
  91. A comparison of pregnancy experience in DES-exposed and DES-unexposed daughters. J Reprod Med. 1980 Feb; 24(2):62-9.
    View in: PubMed
    Score: 0.002
  92. Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1979 Dec 01; 135(7):876-86.
    View in: PubMed
    Score: 0.002
  93. Coitus and the fetus. N Engl J Med. 1979 Nov 29; 301(22):1235-6.
    View in: PubMed
    Score: 0.002
  94. DES-associated clear cell adenocarcinoma of the vagina and cervix. Obstet Gynecol Surv. 1979 Nov; 34(11):844.
    View in: PubMed
    Score: 0.002
  95. A correlative nuclear DNA and histologic study of genital squamous lesions in DES exposed progeny. Obstet Gynecol Surv. 1979 Nov; 34(11):849-50.
    View in: PubMed
    Score: 0.002
  96. Assessment of three sampling technics to detect endometrial cancer and its precursors. A preliminary report. Acta Cytol. 1979 Sep-Oct; 23(5):353-9.
    View in: PubMed
    Score: 0.002
  97. Prenatal diethylstilbestrol exposure and human genital tract abnormalities. Natl Cancer Inst Monogr. 1979 May; (51):25-35.
    View in: PubMed
    Score: 0.002
  98. An analysis of 346 cases of clear cell adenocarcinoma of the vagina and cervix with emphasis on recurrence and survival. Gynecol Oncol. 1979 Apr; 7(2):111-22.
    View in: PubMed
    Score: 0.002
  99. Remission of uterine leiomyosarcomas treated with vincristine, Adriamycin, and dimethyl-triazeno-imidazole carboximide. Am J Obstet Gynecol. 1979 Feb 15; 133(4):379-81.
    View in: PubMed
    Score: 0.002
  100. Preoperative intracavitary brachytherapy in early-stage cervical carcinoma. Am J Clin Oncol. 1999 Feb; 22(1):73-7.
    View in: PubMed
    Score: 0.002
  101. Complications of prenatal therapy with diethylstilbestrol. Pediatrics. 1978 Dec; 62(6 Pt 2):1151-9.
    View in: PubMed
    Score: 0.002
  102. Comparison of histologic and colposcopic findings in DES-exposed females. Obstet Gynecol. 1978 Oct; 52(4):457-61.
    View in: PubMed
    Score: 0.002
  103. A twenty-five-year follow-up study of women exposed to diethylstilbestrol during pregnancy. N Engl J Med. 1978 Apr 06; 298(14):763-7.
    View in: PubMed
    Score: 0.002
  104. Evaluation and management of diethylstilbestrol-exposed offspring. Surg Clin North Am. 1978 Feb; 58(1):87-96.
    View in: PubMed
    Score: 0.002
  105. Pathology of prenatal diethylstilbestrol exposure. Pathol Annu. 1978; 13 Pt 1:201-16.
    View in: PubMed
    Score: 0.002
  106. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. Am J Obstet Gynecol. 1977 May 01; 128(1):43-50.
    View in: PubMed
    Score: 0.002
  107. Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero. Cancer. 1977 Apr; 39(4 Suppl):1892-5.
    View in: PubMed
    Score: 0.002
  108. Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions. Arch Pathol Lab Med. 1977 Jan; 101(1):1-5.
    View in: PubMed
    Score: 0.002
  109. Cytology of 575 young women with prenatal exposure to diethylstilbestrol. Obstet Gynecol. 1976 Nov; 48(5):511-5.
    View in: PubMed
    Score: 0.002
  110. Angiographic control of pelvic bleeding from treated carcinoma of the cervix. Gynecol Oncol. 1976 Jun; 4(2):144-50.
    View in: PubMed
    Score: 0.002
  111. Nuclear chromatin determination in amniotic fluid cells for prenatal sex prediction in the macaque. Am J Obstet Gynecol. 1976 Apr 01; 124(7):761-3.
    View in: PubMed
    Score: 0.002
  112. Summary of the changes in the human female genital tract as a consequence of maternal diethylstilbestrol therapy. J Toxicol Environ Health Suppl. 1976; 1:13-20.
    View in: PubMed
    Score: 0.002
  113. Vaginal adenosis and other diethylstilbestrol-related abnormalities. Clin Obstet Gynecol. 1975 Sep; 18(3):185-94.
    View in: PubMed
    Score: 0.002
  114. Editorial: Problems in the examination of the DES-exposed female. Obstet Gynecol. 1975 Sep; 46(3):353-5.
    View in: PubMed
    Score: 0.002
  115. Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (des). J Reprod Med. 1975 Jul; 15(1):13-18.
    View in: PubMed
    Score: 0.002
  116. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females. J Reprod Med. 1975 Jul; 15(1):5-11.
    View in: PubMed
    Score: 0.002
  117. Prenatal exposure to stilbestrol. A prospective comparison of exposed female offspring with unexposed controls. N Engl J Med. 1975 Feb 13; 292(7):334-9.
    View in: PubMed
    Score: 0.001
  118. Delayed disease as a consequence of fetal exposure to radiation, infection, and exogenous hormones. Clin Perinatol. 1974 Sep; 1(2):483-90.
    View in: PubMed
    Score: 0.001
  119. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol. Ann Clin Lab Sci. 1974 Jul-Aug; 4(4):222-33.
    View in: PubMed
    Score: 0.001
  120. Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases. Am J Obstet Gynecol. 1974 Jul 01; 119(5):713-24.
    View in: PubMed
    Score: 0.001
  121. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA. 1994 Jun 15; 271(23):1866-9.
    View in: PubMed
    Score: 0.001
  122. The effects of local progesterone on stilbestrol-associated vaginal adenosis. Am J Obstet Gynecol. 1974 Mar 01; 118(5):607-15.
    View in: PubMed
    Score: 0.001
  123. Exogenous hormones in pregnancy. Clin Obstet Gynecol. 1973 Dec; 16(4):37-50.
    View in: PubMed
    Score: 0.001
  124. Avoiding serious infections associated with abdominal hysterectomy: a meta-analysis of antibiotic prophylaxis. Am J Obstet Gynecol. 1993 Nov; 169(5):1119-24.
    View in: PubMed
    Score: 0.001
  125. Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med. 1972 Dec 21; 287(25):1259-64.
    View in: PubMed
    Score: 0.001
  126. Stilbestrol and vaginal cancer in young women. CA Cancer J Clin. 1972 Sep-Oct; 22(5):292-5.
    View in: PubMed
    Score: 0.001
  127. Vaginal and cervical abnormalities after exposure to stilbestrol in utero. Obstet Gynecol. 1972 Sep; 40(3):287-98.
    View in: PubMed
    Score: 0.001
  128. Stilbestrol-adenosis-carcinoma syndrome: geographic distribution. N Engl J Med. 1971 Sep 16; 285(12):691.
    View in: PubMed
    Score: 0.001
  129. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971 04 22; 284(15):878-81.
    View in: PubMed
    Score: 0.001
  130. Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer. 1970 Apr; 25(4):745-57.
    View in: PubMed
    Score: 0.001
  131. Primary carcinoma of the vagina. An analysis of 68 cases. Am J Obstet Gynecol. 1970 Jan 15; 106(2):210-8.
    View in: PubMed
    Score: 0.001
  132. Comparison of the quantity of estrogen receptors in human endometrium and myometrium by steroid-binding assay and enzyme immunoassay based on monoclonal antibodies to human estrophilin. Am J Obstet Gynecol. 1989 Mar; 160(3):592-7.
    View in: PubMed
    Score: 0.001
  133. The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy. Gynecol Oncol. 1989 Feb; 32(2):236-9.
    View in: PubMed
    Score: 0.001
  134. [Familial progressive myoclonus epilepsy (Unverricht/Lundborg)]. Psychiatr Neurol Med Psychol Beih. 1967; 6:18-39.
    View in: PubMed
    Score: 0.001
  135. Hyperthyroidism during pregnancy. N Engl J Med. 1965 Sep 16; 273(12):627-33.
    View in: PubMed
    Score: 0.001
  136. Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assays. Lab Invest. 1985 Sep; 53(3):349-61.
    View in: PubMed
    Score: 0.001
  137. Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle. Lab Invest. 1984 Nov; 51(5):495-503.
    View in: PubMed
    Score: 0.001
  138. Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring. Cancer. 1984 Sep 01; 54(5):869-75.
    View in: PubMed
    Score: 0.001
  139. A quality-control procedure on cervical lesions for the comparison of cytology and histology. J Reprod Med. 1983 Dec; 28(12):811-22.
    View in: PubMed
    Score: 0.001
  140. Combined antithyroid-thyroid therapy of hyperthyroidism in pregnancy. Obstet Gynecol. 1963 May; 21:543-50.
    View in: PubMed
    Score: 0.001
  141. Topographic relation of cervical ectropion and vaginal adenosis to clear cell adenocarcinoma. Obstet Gynecol. 1982 Nov; 60(5):546-51.
    View in: PubMed
    Score: 0.001
  142. Clear cell adenocarcinoma of the vagina and cervix in black females. J Natl Med Assoc. 1982 Jul; 74(7):639-43.
    View in: PubMed
    Score: 0.001
  143. Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol. 1978 Apr; 51(4):453-8.
    View in: PubMed
    Score: 0.000
  144. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones. Cancer Res. 1977 Apr; 37(4):1249-51.
    View in: PubMed
    Score: 0.000
  145. Clear-cell adenocarcinoma of the vagina and cervix in young females: analysis of 37 tumors that persisted or recurred after primary therapy. Cancer. 1974 Sep; 34(3):606-14.
    View in: PubMed
    Score: 0.000
  146. Cytology of clear-cell adenocarcinoma of genital tract in young females: review of 95 cases from the registry. Acta Cytol. 1974 Jul-Aug; 18(4):279-90.
    View in: PubMed
    Score: 0.000
  147. Familial hyperthecosis: comparison of endocrinologic and histologic findings with polycystic ovarian disease. Am J Obstet Gynecol. 1973 Dec 01; 117(7):976-82.
    View in: PubMed
    Score: 0.000
  148. Registry of clear-cell carcinoma of genital tract in young women. N Engl J Med. 1971 Aug 12; 285(7):407.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.